Shopping Cart

Europe Blood Screening Market _Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

SKU
DBMR742
READ MORE
USD 2,500
Single User License
USD 2,500
Corporate User License
USD 3,200
Europe blood screening market is expected to reach with healthy CAGR of 9.3% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
READ MORE
  • Details
  • Table Of Content
  • Licence Rights
  • Section Purchase
  • Products and Companies

Market Definition

Blood is an essential requirement for health care which helps in the proper functioning of the human body. A blood screening is defined as a medical process for the detection of disease. The process of blood screening is carried out for a variety of reasons in which the most common reason is pregnancy, human immunodeficiency (HIV) and blood type screenings. Screening of the blood may also be done to detect conditions such as general infections and cancer. Different types of assays are performed in detecting health related problems. Collected blood is screened with different techniques such as ELISA, NAT technology, next generation sequencing and many others. EIAs, particle agglutination (rapid tests) and (Chemiluminescence Immunoassays) CLIAs assays are used for blood screening. Most (Chemiluminescence Immunoassays) CLIAs consists greater specificity and sensitivity as compare to rapid tests that provides better result in screening process.

Europe blood screening market is expected to reach with healthy CAGR of 9.3% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.

Market Segmentation

By Products & Services (Reagents & Kits, Instruments, Software & Services), Technology (Enzyme-Linked Immunosorbent Assay, Rapid Tests, Next-Generation Sequencing, Nucleic Acid Test, Western Blot Assay, Others), Disease Type (Oncology, Diabetes Mellitus, Cold & Flu, Cholesterol, Infectious Diseases, Respiratory Diseases, HIV/AIDS, Others), End User (Diagnostic Centers, Blood Bank, Hospitals, Clinics, Ambulatory Surgical Centers), Geography (North America, Europe, Asia-Pacific, South America, Middle East & Africa)

Major growing sectors under the market segmentation are as follows:

In products & services, reagents are dominating this market as reagents are majorly used in laboratory, company and other places to perform experiment and also to find or detect the diseases related to human health.

In technology, enzyme-linked immunosorbent assay (ELISA) is dominating this market as it is more used with accurate result and less costly in the market. It is a versatile tool for physicians, laboratories, and medical professionals all over the world.

In disease type, oncology is dominating this market as increasing population is detecting more with cancer cases due to exposure to UV lights in today's world. The Blood screening method is found to be more useful for detecting cancer.

In end user, diagnostic centers is dominating this market as people mostly prefer diagnostics centers and doctors also suggest patients to visit diagnostics center for detection of diseases.

The key market players for Europe blood screening market are listed below:

Enzo Biochem Inc.

Meridian Bioscience, Inc.

Bio-Rad Laboratories, Inc.

Thermo Fisher Scientific Inc.

BD

bioMerieux SA

Beckman Coulter, Inc.

Abbott

F. Hoffmann-La Roche Ltd

Cepheid

Grifols

Seimens AG

Ortho Clinical Diagnostics

Immucor, Inc.

Hologic Inc.

READ MORE

Scope

TABLE OF CONTENTS

1 INTRODUCTION 30

1.1 OBJECTIVES OF THE STUDY 30

1.2 MARKET DEFINITION 30

1.3 OVERVIEW OF EUROPE BLOOD SCREENING MARKET 30

1.4 CURRENCY AND PRICING 31

1.5 LIMITATION 32

1.6 MARKETS COVERED 32

2 MARKET SEGMENTATION 36

2.1 MARKETS COVERED 36

2.2 GEOGRAPHIC SCOPE 37

2.3 YEARS CONSIDERED FOR THE STUDY 38

2.4 CURRENCY AND PRICING 38

2.5 RESEARCH METHODOLOGY 39

2.6 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 42

2.7 DBMR MARKET POSITION GRID 43

2.8 THE CATEGORY VS TIME GRID 44

2.9 THE CATEGORY VS TIME GRID 45

2.10 DBMR MARKET CHALLENGE MATRIX 46

2.11 SECONDARY SOURCES 47

2.12 ASSUMPTIONS 47

3 MARKET OVERVIEW 48

3.1 DRIVERS 50

3.1.1 RISE IN THE DEMAND OF BLOOD DONATIONS AND BLOOD DONORS 50

3.1.2 RISING PREVALENCE IN NUMBER OF DISEASES 50

3.1.3 RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS 51

3.2 RESTRAINTS 52

3.2.1 LACK OF USING NAT TECHNLOGY IN EMERGING COUNTRIES 52

3.2.2 HIGH COST OF TECHNOLOGY AND INSTRUMENTS 52

3.2.3 EMERGING ALTERNATIVE TECHNOLOGIES 53

3.3 OPPORTUNITIES 54

3.3.1 INCREASING MICROBIOLOGY SCREENING & MULTIPLEXING 54

3.4 CHALLENGES 55

3.4.1 REDUCTION IN PRICE FOR TECHNOLOGY AND INSTRUMENT 55

4 EXECUTIVE SUMMARY 56

5 PREMIUM INSIGHTS 59

6 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES 61

6.1 OVERVIEW 62

6.2 REAGENTS & KITS 64

6.2.1 ELISA REAGENTS & KITS 66

6.2.1.1 IMMUNOSORBENTS 67

6.2.1.2 CONJUGATES 67

6.2.1.3 SUBSTRATES 67

6.2.1.4 CONTROLS 67

6.2.1.5 SAMPLE DILUENTS AND WASH SOLUTIONS 67

6.2.2 NAT REAGENTS & KITS 67

6.2.2.1 PROBES AND PRIMERS 68

6.2.2.2 ENZYMES AND POLYMERASES 68

6.2.2.3 LABELING AND DETECTION REAGENTS 68

6.2.2.4 STANDARDS AND CONTROLS 68

6.2.2.5 BUFFERS, NUCLEOTIDES AND SOLUTIONS 68

6.3 INSTRUMENTS 69

6.3.1.1 INSTRUMENTS, PRODUCT TYPE 70

6.3.1.1.1 SEMI AUTOMATED 70

6.3.1.1.2 AUTOMATED 70

6.3.1.2 INSTRUMENTS, PURCHASE TYPE 70

6.3.1.2.1 OUTRIGHT PURCHASE 70

6.3.1.2.2 RENTAL 70

6.4 SOFTWARE & SERVICES 71

7 EUROPE BLOOD SCREENING MARKET, BY TECHNOLOGY 72

7.1 OVERVIEW 73

7.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) 75

7.2.1 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY PLATFORM 77

7.2.1.1 COLORIMETRIC IMMUNOASSAY (CI) 77

7.2.1.2 CHEMILUMINESCENCE IMMUNOASSAY (CLIA) 77

7.2.1.3 FLUORESCENCE IMMUNOASSAY (FIA) 77

7.2.2 ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA), BY GENERATIONS 77

7.2.2.1 FIRST-GENERATION ELISA 77

7.2.2.2 SECOND-GENERATION ELISA 77

7.2.2.3 THIRD-GENERATION ELISA 77

7.2.2.4 FOURTH-GENERATION ELISA 77

7.3 RAPID TESTS 78

7.4 NEXT-GENERATION SEQUENCING (NGS) 79

7.5 NUCLEIC ACID TEST 80

7.5.1 REAL-TIME POLYMERASE CHAIN REACTION (PCR) 81

7.5.2 TRANSCRIPTION-MEDIATED AMPLIFICATION (TMA) 81

7.6 WESTERN BLOT ASSAY 82

7.7 OTHERS 83

8 EUROPE BLOOD SCREENING MARKET, BY DISEASE TYPE 84

8.1 OVERVIEW 85

8.2 ONCOLOGY 87

8.3 DIABETES MELLITUS 88

8.4 COLD & FLU 89

8.5 CHOLESTEROL 90

8.6 INFECTIOUS DISEASES 91

8.7 RESPIRATORY DISEASES 92

8.8 HIV/AIDS 93

8.9 OTHERS 94

9 EUROPE BLOOD SCREENING MARKET, BY END USER 95

9.1 OVERVIEW 96

9.2 DIAGNOSTIC CENTERS 98

9.3 BLOOD BANK 99

9.4 HOSPITALS 100

9.5 CLINICS 101

9.6 AMBULATORY SURGICAL CENTERS 102

10 EUROPE BLOOD SCREENING MARKET, BY GEOGRAPHY 103

10.1 EUROPE 103

10.1.1 GERMANY 114

10.1.2 U.K. 121

10.1.3 FRANCE 128

10.1.4 ITALY 135

10.1.5 SPAIN 142

10.1.6 SWITZERLAND 149

10.1.7 NETHERLANDS 156

10.1.8 BELGIUM 163

10.1.9 RUSSIA 170

10.1.10 TURKEY 177

10.1.11 REST OF EUROPE 184

11 EUROPE BLOOD SCREENING MARKET, COMPANY LANDSCAPE 185

11.1 COMPANY SHARE ANALYSIS: EUROPE 185

12 COMPANY PROFILES 186

12.1 F. HOFFMANN-LA ROCHE LTD 186

12.1.1 COMPANY OVERVIEW 186

12.1.2 REVENUEANALYSIS 186

12.1.3 COMPANY SHARE ANALYSIS 187

12.1.4 PRODUCT PORTFOLIO 187

12.1.5 RECENT DEVELOPMENT 188

12.2 ABBOTT 189

12.2.1 COMPANY OVERVIEW 189

12.2.2 REVENUE ANALYSIS 189

12.2.3 COMPANY SHAREV ANALYSIS 190

12.2.4 PRODUCT PORTFOLIO 190

12.2.5 RECENT DEVELOPMENT 191

12.3 THERMO FISHER SCIENTIFIC INC. 192

12.3.1 COMPANY OVERVIEW 192

12.3.2 REVENUE ANALYSIS 192

12.3.3 COMPANY SHAREV ANALYSIS 193

12.3.4 PRODUCT PORTFOLIO 193

12.3.5 RECENT DEVELOPMENTS 194

12.4 SIEMENS AG 195

12.4.1 COMPANY OVERVIEW 195

12.4.2 REVENUE ANALYSIS 195

12.4.3 COMPANY SHAREV ANALYSIS 196

12.4.4 PRODUCT PORTFOLIO 196

12.4.5 RECENT DEVELOPMENTS 198

12.5 BIO-RAD LABORATORIES, INC. 199

12.5.1 1.3.1COMPANY OVERVIEW 199

12.5.2 REVENUE ANALYSIS 199

12.5.3 COMPANY SHAREV ANALYSIS 200

12.5.4 PRODUCT PORTFOLIO 200

12.5.5 RECENT DEVELOPMENTS 202

12.6 BD 203

12.6.1 COMPANY OVERVIEW 203

12.6.2 REVENUE ANALYSIS 203

12.6.3 PRODUCT PORTFOLIO 204

12.6.4 RECENT DEVELOPMENTS 204

12.7 BECKMAN COULTER, INC. 205

12.7.1 COMPANY OVERVIEW 205

12.7.2 GEOGRAPHICPRESENCE 205

12.7.3 PODUCT PORTFOLIO 206

12.7.4 RECENET DEVELOPEMENTS 207

12.8 BIOMERIEUX SA 208

12.8.1 COMPANY OVERVIEW 208

12.8.2 REVENUE ANALYSIS 208

12.8.3 PRODUCT PORTFOLIO 209

12.8.4 RECENT DEVELOPMENT 210

12.9 CEPHEID (A SUBSIDIARY OF DANAHER CORPORATION) 211

12.9.1 COMPANY OVERVIEW 211

12.9.2 GEOGRAPHIC PRESENCE 211

12.9.3 PRODUCT PORTFOLIO 212

12.9.4 RECENT DEVELOPMENT 213

12.10 ENZO BIOCHEM INC. 214

12.10.1 COMPANY OVERVIEW 214

12.10.2 REVENUE ANALYSIS 214

12.10.3 PRODUCT PORTFOLIO 215

12.10.4 RECENT DEVELOPMENTS 216

12.11 GRIFOLS INTERNATIONAL, S.A. 217

12.11.1 COMPANY OVERVIEW 217

12.11.2 REVENUE ANALYSIS 217

12.11.3 PRODUCT PORTFOLIO 218

12.11.4 RECENT DEVELOPMENTS 219

12.12 HOLOGIC INC. 220

12.12.1 COMPANY OVERVIEW 220

12.12.2 REVENUE ANALYSIS 220

12.12.3 PRODUCT PORTFOLIO 221

12.12.4 RECENT DEVELOPMENTS 221

12.13 IMMUCOR, INC. 222

12.13.1 COMPANY OVERVIEW 222

12.13.2 GEOGRAPHIC PRESENCE: 222

12.13.3 PRODUCT PORTFOLIO 223

12.13.4 RECENT DEVELOPMENTS 224

12.14 MERIDIAN BIOSCIENCE, INC. 225

12.14.1 COMPANY OVERVIEW 225

12.14.2 REVENUE ANALYSIS 225

12.14.3 PRODUCT PORTFOLIO 226

12.14.4 RECENT DEVELOPMENTS 227

12.15 ORTHO CLINICAL DIAGNOSTICS 228

12.15.1 COMPANY OVERVIEW 228

12.15.2 GEOGRAPHIC PRESENCE 228

12.15.3 PRODUCT PORTFOLIO 229

12.15.4 RECENT DEVELOPMENTS 230

13 RELATED REPORTS 231

?


List Of Figure

LIST OF FIGURES

FIGURE 1 EUROPE BLOOD SCREENING MARKET: SEGMENTATION 24

FIGURE 2 EUROPE BLOOD SCREENING MARKET: DATA TRIANGULATION 27

FIGURE 3 EUROPE BLOOD SCREENING MARKET: DROC ANALYSIS 28

FIGURE 4 EUROPE BLOOD SCREENING MARKET:BOTTOM UP APPROACH 29

FIGURE 5 EUROPE BLOOD SCREENING MARKET:TOP DOWN APPROACH 29

FIGURE 6 EUROPE BLOOD SCREENING MARKET: INTERVIEW DEMOGRAPHICS 30

FIGURE 7 EUROPE BLOOD SCREENING MARKET: DBMR MARKET POSITION GRID 31

FIGURE 8 EUROPE BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID 32

FIGURE 9 EUROPE BLOOD SCREENING MARKET: THE CATEGORY VS TIME GRID 33

FIGURE 10 EUROPE BLOOD SCREENING MARKET: THE MARKET CHALLENGE MATRIX 34

FIGURE 11 DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES OF EUROPE BLOOD SCREENING MARKET 37

FIGURE 12 EUROPE BLOOD SCREENING MARKET: SEGMENTATION 46

FIGURE 13 RISE IN DEMAND OF BLOOD DONATIONS AND BLOOD DONORS AS WELL AS RISING NUMBER OF INITIATIVES BY VARIOUS GOVERNMENTS AND GOVERNMENT ASSOCIATIONS EXPECTED TO DRIVE THE MARKET FOR BLOOD SCREENING MARKET IN THE FORECAST PERIOD 2018 TO 2025 47

FIGURE 14 REAGENTS & KITS IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE BLOOD SCREENING MARKET IN 2018 & 2025 48

FIGURE 15 EUROPE BLOOD SCREENING MARKET: BY PRODUCTS & SERVICES, 2017 50

FIGURE 16 EUROPE BLOOD SCREENING MARKET: BY TECHNOLOGY, 2017 61

FIGURE 17 EUROPE BLOOD SCREENING MARKET: BY DISEASE TYPE, 2017 73

FIGURE 18 EUROPE BLOOD SCREENING MARKET: BY END USER, 2017 84

FIGURE 19 EUROPE BLOOD SCREENING MARKET SNAPSHOT (2017) 91

FIGURE 20 EUROPE BLOOD SCREENING MARKET: BY COUNTRY (2017) 92

FIGURE 21 EUROPE BLOOD SCREENING MARKET: BY COUNTRY (2018 & 2025) 92

FIGURE 22 EUROPE BLOOD SCREENING MARKET BY COUNTRY (2017 & 2025) 93

FIGURE 23 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES (2018 TO 2025) 93

FIGURE 24 ASIA-PACIFIC BLOOD SCREENING MARKET: COMPANY SHARE 2017 (%) 173


List Of Table

LIST OF TABLES

TABLE 1 LIST OF PRICES FOR FEW DEVICES 42

TABLE 2 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025, (USD MILLION) 52

TABLE 3 EUROPE REAGENTS & KITS IN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 53

TABLE 4 EUROPE REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 54

TABLE 5 EUROPE ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 55

TABLE 6 EUROPE NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 56

TABLE 7 EUROPE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 58

TABLE 8 EUROPE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 58

TABLE 9 EUROPE INSTRUMENTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 59

TABLE 10 EUROPE SOFTWARE & SERVICES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 60

TABLE 11 EUROPE BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 63

TABLE 12 EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 64

TABLE 13 EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 65

TABLE 14 EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY REGION , 2016-2025 (USD MILLION) 65

TABLE 15 EUROPE RAPID TESTS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 67

TABLE 16 EUROPE NEXT-GENERATION SEQUENCING (NGS) IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 68

TABLE 17 EUROPE NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 69

TABLE 18 EUROPE NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 69

TABLE 19 EUROPE WESTERN BLOT ASSAY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 71

TABLE 20 EUROPE OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 72

TABLE 21 EUROPE BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 75

TABLE 22 EUROPE ONCOLOGY IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 76

TABLE 23 EUROPE DIABETES MELLITUS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 77

TABLE 24 EUROPE COLD & FLU IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 78

TABLE 25 EUROPE CHOLESTEROL IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 79

TABLE 26 EUROPE INFECTIOUS DISEASES IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 80

TABLE 27 EUROPE RESPIRATORY DISEASESIN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 81

TABLE 28 EUROPE HIV/AIDS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 82

TABLE 29 EUROPE OTHERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 83

TABLE 30 EUROPE BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 86

TABLE 31 EUROPE DIAGNOSTIC CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 87

TABLE 32 EUROPE BLOOD BANK IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 88

TABLE 33 EUROPE HOSPITALS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 89

TABLE 34 EUROPE CLINICS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 90

TABLE 35 EUROPE AMBULATORY SURGICAL CENTERS IN BLOOD SCREENING MARKET, BY REGION, 2016-2025 (USD MILLION) 91

TABLE 36 EUROPE BLOOD SCREENING MARKET, BY COUNTRY, 2016-2025 (USD MILLION) 95

TABLE 37 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 96

TABLE 38 EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 96

TABLE 39 EUROPE ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 97

TABLE 40 EUROPE NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 97

TABLE 41 EUROPE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 98

TABLE 42 EUROPE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 98

TABLE 43 EUROPE BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 99

TABLE 44 EUROPE NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 99

TABLE 45 EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 100

TABLE 46 EUROPE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 100

TABLE 47 EUROPE BLOOD SCREENING MARKET, BY DISEASES TYPE, 2016-2025 (USD MILLION) 101

TABLE 48 EUROPE BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 102

TABLE 49 GERMANY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 103

TABLE 50 GERMANY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 103

TABLE 51 GERMANY ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 104

TABLE 52 GERMANY NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 105

TABLE 53 GERMANY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 105

TABLE 54 GERMANY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 106

TABLE 55 GERMANY BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 106

TABLE 56 GERMANY NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 107

TABLE 57 GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 107

TABLE 58 GERMANY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 108

TABLE 59 GERMANY BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 108

TABLE 60 GERMANY BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 109

TABLE 61 U.K. BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 110

TABLE 62 U.K. BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 110

TABLE 63 U.K. ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 111

TABLE 64 U.K. NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 111

TABLE 65 U.K. INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 112

TABLE 66 U.K. INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 112

TABLE 67 U.K. BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 113

TABLE 68 U.K. NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 113

TABLE 69 U.K. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 114

TABLE 70 U.K. ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 114

TABLE 71 U.K. BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 115

TABLE 72 U.K. BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 116

TABLE 73 FRANCE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 117

TABLE 74 FRANCE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 117

TABLE 75 FRANCE ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 118

TABLE 76 FRANCE NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 119

TABLE 77 FRANCE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 119

TABLE 78 FRANCE INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 120

TABLE 79 FRANCE BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 120

TABLE 80 FRANCE NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 121

TABLE 81 FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 121

TABLE 82 FRANCE ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 122

TABLE 83 FRANCE BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 122

TABLE 84 FRANCE BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 123

TABLE 85 ITALY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 124

TABLE 86 ITALY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 124

TABLE 87 ITALY ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 125

TABLE 88 ITALY NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 126

TABLE 89 ITALY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 126

TABLE 90 ITALY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 127

TABLE 91 ITALY BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 127

TABLE 92 ITALY NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 128

TABLE 93 ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 128

TABLE 94 ITALY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 129

TABLE 95 ITALY BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 129

TABLE 96 ITALY BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 130

TABLE 97 SPAIN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 131

TABLE 98 SPAIN BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 131

TABLE 99 SPAIN ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 132

TABLE 100 SPAIN NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 133

TABLE 101 SPAIN INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 133

TABLE 102 SPAIN INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 134

TABLE 103 SPAIN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 134

TABLE 104 SPAIN NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 135

TABLE 105 SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 135

TABLE 106 SPAIN ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 136

TABLE 107 SPAIN BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 136

TABLE 108 SPAIN BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 137

TABLE 109 SWITZERLAND BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 138

TABLE 110 SWITZERLAND BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 138

TABLE 111 SWITZERLAND ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 139

TABLE 112 SWITZERLAND NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 140

TABLE 113 SWITZERLAND INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 140

TABLE 114 SWITZERLAND INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 141

TABLE 115 SWITZERLAND BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 141

TABLE 116 SWITZERLAND NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 142

TABLE 117 SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 142

TABLE 118 SWITZERLAND ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 143

TABLE 119 SWITZERLAND BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 143

TABLE 120 SWITZERLAND BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 144

TABLE 121 NETHERLANDS BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 145

TABLE 122 NETHERLANDS BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 145

TABLE 123 NETHERLANDS ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 146

TABLE 124 NETHERLANDS NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 147

TABLE 125 NETHERLANDS INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 147

TABLE 126 NETHERLANDS INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 148

TABLE 127 NETHERLANDS BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 148

TABLE 128 NETHERLANDS NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 149

TABLE 129 NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 149

TABLE 130 NETHERLANDS ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 150

TABLE 131 NETHERLANDS BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 150

TABLE 132 NETHERLANDS BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 151

TABLE 133 BELGIUM BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 152

TABLE 134 BELGIUM BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 152

TABLE 135 BELGIUM ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 153

TABLE 136 BELGIUM NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 154

TABLE 137 BELGIUM INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 154

TABLE 138 BELGIUM INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 155

TABLE 139 BELGIUM BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 155

TABLE 140 BELGIUM NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 156

TABLE 141 BELGIUM ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 156

TABLE 142 BELGIUM ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 157

TABLE 143 BELGIUM BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 157

TABLE 144 BELGIUM BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 158

TABLE 145 RUSSIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 159

TABLE 146 RUSSIA BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 159

TABLE 147 RUSSIA ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 160

TABLE 148 RUSSIA NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 161

TABLE 149 RUSSIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 161

TABLE 150 RUSSIA INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 162

TABLE 151 RUSSIA BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 162

TABLE 152 RUSSIA NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 163

TABLE 153 RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 163

TABLE 154 RUSSIA ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 164

TABLE 155 RUSSIA BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 164

TABLE 156 RUSSIA BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 165

TABLE 157 TURKEY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 166

TABLE 158 TURKEY BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 166

TABLE 159 TURKEY ELISA REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 167

TABLE 160 TURKEY NAT REAGENTS & KITS IN BLOOD SCREENING MARKET, BY REAGENTS & KITS, 2016-2025 (USD MILLION) 168

TABLE 161 TURKEY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PRODUCT TYPE, 2016-2025 (USD MILLION) 168

TABLE 162 TURKEY INSTRUMENTS IN BLOOD SCREENING MARKET, BY PURCHASE TYPE, 2016-2025 (USD MILLION) 169

TABLE 163 TURKEY BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 169

TABLE 164 TURKEY NUCLEIC ACID TEST IN BLOOD SCREENING MARKET, BY TECHNOLOGY, 2016-2025 (USD MILLION) 170

TABLE 165 TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY PLATFORM, 2016-2025 (USD MILLION) 170

TABLE 166 TURKEY ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA) IN BLOOD SCREENING MARKET, BY GENERATION, 2016-2025 (USD MILLION) 171

TABLE 167 TURKEY BLOOD SCREENING MARKET, BY DISEASE TYPE, 2016-2025 (USD MILLION) 171

TABLE 168 TURKEY BLOOD SCREENING MARKET, BY END USER, 2016-2025 (USD MILLION) 172

TABLE 169 REST OF EUROPE BLOOD SCREENING MARKET, BY PRODUCTS & SERVICES, 2016-2025 (USD MILLION) 173

To know more information on Purchase by Section, please send a mail to

Companies

Enzo Biochem Inc.

Meridian Bioscience, Inc.

Bio-Rad Laboratories, Inc.

Thermo Fisher Scientific Inc.

BD

bioMerieux SA

Beckman Coulter, Inc.

Abbott

F. Hoffmann-La Roche Ltd

Cepheid

Grifols

Seimens AG

Ortho Clinical Diagnostics

Immucor, Inc.

Hologic Inc.

Brand Description
History Color sit amet, consectetur adipiscing elit. In gravida pellentesque ligula, vel eleifend turpis blandit vel. Nam quis lorem ut mi mattis ullamcorper ac quis dui. Vestibulum et scelerisque ante, eu sodales mi. Nunc tincidunt tempus varius. Integer ante dolor, suscipit non faucibus a, scelerisque vitae sapien.